Startups
TerSera Therapeutics LLC acquires and develops specialty pharmaceutical products with a focus on select therapeutic areas.
Overview
Employees
51-200
Founded date
2016
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 5, 2021 | TerSera® Presents Data on cetirizine HCL Injection (QUZYTTIR®) in the Prevention of Hypersensitivity Infusion Reactions in Patients with Breast Cancer and Other Malignancies | |
| Feb 23, 2021 | TerSera® Announces Addition Of Cetirizine As An Adjunctive Treatment To Interim CDC Guidelines For Managing Adverse Reactions After COVID-19 Vaccination |
Reviews 0
FAQ about TerSera Therapeutics USA
When was TerSera Therapeutics USA founded?
TerSera Therapeutics USA was founded in 2016.
What has the press written about TerSera Therapeutics USA?
Parsers VC has collected 3 articles mentioning TerSera Therapeutics USA, among them “TerSera® Presents Data on cetirizine HCL Injection (QUZYTTIR®) in the Prevention of Hypersensitivity Infusion Reactions in Patients with Breast Cancer and Ot...” (Mar 5, 2021) and “TerSera® Announces Addition Of Cetirizine As An Adjunctive Treatment To Interim CDC Guidelines For Managing Adverse Reactions After COVID-19 Vaccination” (Feb 23, 2021).
Is TerSera Therapeutics USA still active?
Yes, TerSera Therapeutics USA is active; its latest activity on Parsers VC dates from Jul 30, 2026.